Fundraising Fox

Receptor Life Sciences

Seattle, US · Founded 2015 · Washington corporation · 1 known investors

Founders & leadership

GW
Gregory WesnerNamed on SEC filing
DT
David ThomsonNamed on SEC filing
AR
Arthur RubinfeldNamed on SEC filing
TC
Traci CarmanNamed on SEC filing

Investors · 1

Granite Point Capitalreported

Reported raises · per SEC filings

Form D private placements

$7.6M disclosed across 1 round · 2016

▶$7.6MraisedOct 2018 · 55 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Gregory WesnerDirector
  • David ThomsonDirector
  • Arthur RubinfeldDirector
  • Traci CarmanExecutive Officer, Director
Offering amount
$7.6M
Amount sold
$7.6M
Minimum investment
$25K
First sale
Dec 2016
Incorporated
Corporation, Washington, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Receptor Life Sciences Secures $9.7 Million Financing to Advance RLS103 (Inhaled Dry Powder CBD) into Clinical Trials - Neuro Centralneuro-central.com · Apr 2022Seattle startup raises $9.7M for clinical trial to test inhaled CBD as anxiety treatment – GeekWiregeekwire.com · Apr 2022Receptor Holdings Secures $29M in Funding Round - FinSMEsfinsmes.com · Oct 2018Receptor Life Sciences raises $29M, unveils its work on inhaler for medicines based on cannabis – GeekWiregeekwire.com · Oct 2018Secretive startup Receptor Life Sciences raises $7.5M for therapies based on 'plant extracts' – GeekWiregeekwire.com · Oct 2018

Frequently asked questions

Who are Receptor Life Sciences's investors?
Receptor Life Sciences's investors include Granite Point Capital.
How much funding has Receptor Life Sciences raised?
Receptor Life Sciences has disclosed $7.6M raised across 1 round.
Where is Receptor Life Sciences headquartered?
Receptor Life Sciences is headquartered in Seattle, US.